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Introduction
Pentraxin-3 (PTX-3) is a long pentraxin that is structurally
related to the short pentraxins as C-reactive protein (CRP).
It is known to play an important role in innate immunity
and inflammatory regulation. CRP and serum amyloid A
(SAA) are sensitive and reliable markers of inflammation
in FMF attack as well as chronic and subclinical inflamma-
tion during attack-free period. To date, there is no infor-
mation about PTX-3 in FMF inflammation.
Aim
The aim of the study was to investigate the progress of
serum PTX-3 levels together with traditional acute
phase reactants in FMF patients during attack and
attack free period (two weeks after the attack) and also
assess whether PTX-3 could be related with subclinical
inflammation.
Material and method
A prospective cross-sectional study was conducted
between June 2013 and July 2014. A total of 45 consecutive
children with FMF who were diagnosed according to the
Tel-Hashomer and Yalçınkaya criteria were enrolled during
the attack period. Blood samples were obtained from the
patients during attack and attack free period (two weeks
after the attack) and healthy children who were matched in
terms of age and sex.
Results
The study group consisted of 45 children with FMF
(24 boys, 21 girls, mean age 9.5±3.8 years) and 40
healthy children. In FMF patients attack white blood
cell (WBC) count, CRP, erythrocyte sedimentation rate
(ESR), fibrinogen, SAA and PTX-3 levels were signifi-
cantly higher than attack-free period and healthy sub-
jects. In attack-free period, there were no significant
differences between patients and healthy children in
terms of WBC, CRP levels. Although mean attack-free
period ESR, fibrinogen and SAA levels were higher
than the controls, those markers were within the nor-
mal range. Whereas, mean attack-free PTX-3 level was
still significantly higher than controls.
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Table 1
During Attack (Mean±SD) After Attack (Mean±SD) Controls (Mean±SD) P1 P2 P3
WBC (x109/L) 12.1±4.6 8.1±2.5 8.2±2.5 <0.001 <0.001 >0.05
MPV (fL) 7.5±0.70 7.6±0.58 7.3±0.57 >0.05 >0.05 >0.05
CRP (mg/dL) (normal: 0-1) 4.7±4.2 0.15±0.19 0.11±0.15 <0.001 <0.001 >0.05
ESR (mm/hour) (normal < 20) 44.1±20.8 13.9±7.24 6.6±4.5 <0.001 <0.001 <0.001
Fibrinogen (mg/dL) (normal: 180-350) 371.0±70.9 257.0±55.3 220±45 <0.001 <0.001 <0.001
SAA (mg/L) (normal: 0-7) 306.5±283.1 5.5±3.8 4.1±1.2 <0.001 <0.001 0.032
Pentraxin-3 (ng/mL) 3.2±0.6 1.89±0.14 0.87±0.38 <0.001 <0.001 <0.001
P1: During attack vs after attack, P2: During attack vs controls, P3: After attack vs controls
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Conclusion
Serum PTX-3 levels increased during the attacks of FMF
and decreased during the attack free period however
mean level of it was still higher than healthy subjects.
We suggest that PTX-3 might be a new marker for both
attack period and subclinical inflammation in FMF
patients.
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